Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
In the world economic growth, the Cytokines Industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Cytokines market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2019, SMI analysts believe that in the next few years, Cytokines market size will be further expanded, we expect that by 2024, The market size of the Cytokines will reach XXX million $.
Cytokines are the cell-signaling chemical that supports cell to cell communication in immune responses and enable the movement of cells towards the direction of infection, inflammation, and trauma. Cytokines are broadly used across diagnostic and therapeutic applications. Tumor Necrosis Factor-TNF, Interleukins-Il, Interferons-IFN, and Epidermal Growth Factor-EGF are some of the types of cytokines. Cytokines based therapies are used to treat inflammatory & immune disorders, cancer & malignancies, and infectious diseases. Interferons (INFs) and interleukins (ILs) are the two types of cytokines used to treat patients with cancer and have proven to be very effective in cancer treatment.
Rising cases of cancers around the globe are expected to fuel the market growth of the cytokines. According to the World Health Organization, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. Increasing the launch of cytokines based therapies by major players is further projected to augment the market growth of cytokines. For instance, in February 2020, Boehringer Ingelheim and Trutino Biosciences announced that they have entered into a research partnership and worldwide licensing agreement for Trutino’s innovative On-Demand-Cytokine (ODC) platform. As per the terms of strategic alliance, Boehringer Ingelheim gains access to Trutino’s ODC platform technology for the generation and development of up to three new ODC candidates.
From the regional analysis, North America is expected to gain significant growth over the forecast period and this is attributed to the high prevalence of the immune disorder in the region coupled with the increasing number of clinical trials for introducing cancer-based drugs. For instance, in August 2019, researchers have introduced a clinical trial to test and study an immunotherapy drug in patients with both cancer and autoimmune diseases, such as rheumatoid arthritis, lupus, or multiple sclerosis.
Key Developments:
- In August 2019, IsoPlexis, the life sciences company in the single-cell functional biology space, has adopted its innovative IsoLight single-cell cytokine detection system at the Karolinska Institute in Sweden, for expanding its business into Europe.
- In May 2018, Bio-Rad Laboratories, Inc. announced the introduction of the Bio-Plex Pro Human Cytokine Screening Panel, the first validated high-performance multiplex assay on the market.
- In February 2019, Genentech, a member of the Roche Group, partnered with Xencor to produce and commercialize its novel IL-15 cytokine therapeutics—including its most advanced preclinical cytokine program, the cancer candidate XmAb®24306.
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers. If you need more information, please contact SMI
Section 1: Definition
Section (2 3): Manufacturer Detail
✑ AbbVie
✑ Johnson & Johnson
✑ GlaxoSmithKline
✑ Novartis
✑ Roche
✑ Pfizer
✑ Sanofi
✑ Bayer HealthCare Pharmaceuticals
✑ Thermo Fisher Scientific
✑ Biocon
Section 4: Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7): Segmentation
Product Type Segmentation:
✑ TNF
✑ IL
✑ IFN
✑ EGF
Industry Segmentation:
✑ Cancer and Malignancy
✑ Asthma / Airway Inflammation
✑ Arthritis
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2019-2024)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
